Answers are grounded in this paper and cite their sources.
Although statin and aspirin use were associated with reduced HCC risk, only statin use was significant in subgroup analyses accounting for concurrent medications. Metformin use was not associated with reduced HCC risk. These data have implications for future clinical trial design.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: